SIRT2, a tubulin deacetylase, acts to block the entry to chromosome condensation in response to mitotic stress.
We previously identified SIRT2, an nicotinamide adenine dinucleotide (NAD)-dependent tubulin deacetylase, as a protein downregulated in gliomas and glioma cell lines, which are characterized by aneuploidy. Other studies reported SIRT2 to be involved in mitotic progression in the normal cell cycle. We herein investigated whether SIRT2 functions in the mitotic checkpoint in response to mitotic stress caused by microtubule poisons. By monitoring chromosome condensation, the exogenously expressed SIRT2 was found to block the entry to chromosome condensation and subsequent hyperploid cell formation in glioma cell lines with a persistence of the cyclin B/cdc2 activity in response to mitotic stress. SIRT2 is thus a novel mitotic checkpoint protein that functions in the early metaphase to prevent chromosomal instability (CIN), characteristics previously reported for the CHFR protein. We further found that histone deacetylation, but not the aberrant DNA methylation of SIRT2 5'untranslated region is involved in the downregulation of SIRT2. Although SIRT2 is normally exclusively located in the cytoplasm, the rapid accumulation of SIRT2 in the nucleus was observed after treatment with a nuclear export inhibitor, leptomycin B and ionizing radiation in normal human fibroblasts, suggesting that nucleo-cytoplasmic shuttling regulates the SIRT2 function. Collectively, our results suggest that the further study of SIRT2 may thus provide new insights into the relationships among CIN, epigenetic regulation and tumorigenesis.
Inoue
T
T
Department of Human Genome Science, Graduate School of Medical Science, Tottori University, Yonago, Tottori, Japan.
Hiratsuka
M
M
Osaki
M
M
Yamada
H
H
Kishimoto
I
I
Yamaguchi
S
S
Nakano
S
S
Katoh
M
M
Ito
H
H
Oshimura
M
M
D045744:Cell Line, Tumor; D043171:Chromosomal Instability / Q000187:drug effects / Q000502:physiology* / Q000528:radiation effects; D002877:Chromosomes, Human / Q000187:drug effects / Q000201:enzymology / Q000528:radiation effects; D005910:Glioma / Q000201:enzymology / Q000235:genetics / Q000473:pathology; D056572:Histone Deacetylase Inhibitors; D006655:Histone Deacetylases / Q000502:physiology*; D006801:Humans; D008938:Mitosis / Q000187:drug effects / Q000502:physiology* / Q000528:radiation effects; D015739:Nocodazole / Q000494:pharmacology; D017239:Paclitaxel / Q000494:pharmacology; D011123:Polyploidy; D056565:Sirtuin 2; D037761:Sirtuins / Q000037:antagonists & inhibitors / Q000235:genetics / Q000502:physiology*; D013312:Stress, Physiological / Q000139:chemically induced / Q000201:enzymology* / Q000473:pathology; D014404:Tubulin / Q000502:physiology; D014466:Ultraviolet Rays; D014965:X-Rays
D056572:Histone Deacetylase Inhibitors; D014404:Tubulin; C474199:SIRT2 protein, human; D056565:Sirtuin 2; D037761:Sirtuins; D006655:Histone Deacetylases; D017239:Paclitaxel; D015739:Nocodazole